NovoCure Ltd (NVCR) stock
NVCRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/3027% below fair value
$11.83+0.11 (+0.94%)
Close on Nov 13, 2026Market cap $1.38BP/E –Yield –
NovoCure operating margin
Operating margin is operating income as a percentage of revenue.
NovoCure's operating margin for the twelve months ending Sep 30, 2026 was -17.2%. For fiscal 2025 it was -23.5%, against -28.2% the year before. The highest annual figure on record is 6.1% in fiscal 2020.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -23.5% | +4.7 |
| FY2024 | Dec 31, 2024 | -28.2% | +17.5 |
| FY2023 | Dec 31, 2023 | -45.7% | −29.1 |
| FY2022 | Dec 31, 2022 | -16.6% | −8.4 |
| FY2021 | Dec 31, 2021 | -8.3% | −14.4 |
| FY2020 | Dec 31, 2020 | 6.1% | +6.4 |
| FY2019 | Dec 31, 2019 | -0.3% | +13.3 |
| FY2018 | Dec 31, 2018 | -13.6% | +8.6 |
| FY2017 | Dec 31, 2017 | -22.2% | +116.9 |
| FY2016 | Dec 31, 2016 | -139.1% | +175.2 |
| FY2015 | Dec 31, 2015 | -314.3% | +203.2 |
| FY2014 | Dec 31, 2014 | -517.5% | +104.8 |
| FY2013 | Dec 31, 2013 | -622.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -3.2% | +18.4 |
| Q2 FY2026 | Jun 30, 2026 | -5.8% | +19.1 |
| Q1 FY2026 | Mar 31, 2026 | -38.7% | −14.3 |
| Q4 FY2025 | Dec 31, 2025 | -23.2% | +16.1 |
| Q3 FY2025 | Sep 30, 2025 | -21.5% | −0.9 |
| Q2 FY2025 | Jun 30, 2025 | -24.9% | −2.6 |
| Q1 FY2025 | Mar 31, 2025 | -24.4% | +5.5 |
| Q4 FY2024 | Dec 31, 2024 | -39.3% | −0.6 |
| Q3 FY2024 | Sep 30, 2024 | -20.7% | +25.1 |
| Q2 FY2024 | Jun 30, 2024 | -22.3% | +27.4 |
| Q1 FY2024 | Mar 31, 2024 | -30.0% | +19.3 |
| Q4 FY2023 | Dec 31, 2023 | -38.7% | −5.2 |
| Q3 FY2023 | Sep 30, 2023 | -45.7% | −27.0 |
| Q2 FY2023 | Jun 30, 2023 | -49.7% | −34.7 |
| Q1 FY2023 | Mar 31, 2023 | -49.3% | −48.7 |
| Q4 FY2022 | Dec 31, 2022 | -33.5% | −15.9 |
| Q3 FY2022 | Sep 30, 2022 | -18.8% | −12.4 |
| Q2 FY2022 | Jun 30, 2022 | -15.0% | −5.8 |
| Q1 FY2022 | Mar 31, 2022 | -0.6% | −0.5 |
| Q4 FY2021 | Dec 31, 2021 | -17.6% | −26.0 |
| Q3 FY2021 | Sep 30, 2021 | -6.4% | −17.7 |
| Q2 FY2021 | Jun 30, 2021 | -9.2% | −15.0 |
| Q1 FY2021 | Mar 31, 2021 | -0.1% | +3.3 |
| Q4 FY2020 | Dec 31, 2020 | 8.4% | +8.2 |
| Q3 FY2020 | Sep 30, 2020 | 11.3% | +7.1 |
| Q2 FY2020 | Jun 30, 2020 | 5.8% | +4.4 |
| Q1 FY2020 | Mar 31, 2020 | -3.3% | +5.0 |
| Q4 FY2019 | Dec 31, 2019 | 0.2% | +12.6 |
| Q3 FY2019 | Sep 30, 2019 | 4.2% | +12.3 |
| Q2 FY2019 | Jun 30, 2019 | 1.4% | +12.9 |
| Q1 FY2019 | Mar 31, 2019 | -8.3% | +16.0 |
| Q4 FY2018 | Dec 31, 2018 | -12.4% | −4.0 |
| Q3 FY2018 | Sep 30, 2018 | -8.1% | +3.7 |
| Q2 FY2018 | Jun 30, 2018 | -11.5% | +29.0 |
| Q1 FY2018 | Mar 31, 2018 | -24.3% | +14.0 |
| Q4 FY2017 | Dec 31, 2017 | -8.4% | +50.7 |
| Q3 FY2017 | Sep 30, 2017 | -11.8% | – |
| Q2 FY2017 | Jun 30, 2017 | -40.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -38.3% | – |
| Q4 FY2016 | Dec 31, 2016 | -59.1% | – |
See a number that looks wrong?